Oxford COVID-19 vaccine producing positive results on initial trials – ITV
|Oxford's COVID-19 vaccine that is backed by AstraZeneca is reportedly generating "the kind of antibody and T-cell (killer cell) response that the researchers would hope to see," Robert Peston, ITV News’ political editor, wrote on Wednesday.
"As I understand, not all of the many vaccines under development across the world increase both antibodies and T-cells. But the Oxford vaccine looks as though it has this twin effect," Peston added.
Market reaction
Risk-on flows continue to dominate financial markets on Wednesday. As of writing, major equity indexes in Europe were up between 0.95% and 1.2% and the S&P 500 were gaining 0.8% on the day.
Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers.